[1] Medici D, Kalluri R. Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype [J]. Semin Cancer Biol, 2012, 22(5-6): 379-384. [2] Laurent F, Girdziusaite A, Gamart J, et al. HAND2 target gene regulatory networks control atrioventricular canal and cardiac valve development [J]. Cell Rep, 2017, 19(8): 1602-1613. [3] Li Y, Lui KO, Zhou B. Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases [J]. Nat Rev Cardiol, 2018, 15(8): 445-456. [4] Evrard SM, Lecce L, Michelis KC, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability [J]. Nat Commun, 2016, 7:11853. [5] Kalluri R. The biology and function of fibroblasts in cancer [J]. Nat Rev Cancer, 2016, 16(9): 582-598. [6] Shi Y, Du L, Lin L, et al. Tumour-associated mesenchymal stem/stromal cells: emerging therapeutic targets [J]. Nat Rev Drug Discov, 2017, 16(1): 35-52. [7] Zeisberg EM, Potenta S, Xie L, et al. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts [J]. Cancer Res, 2007, 67(21): 10123-10128. [8] Welch-Reardon KM, Ehsan SM, Wang K, et al. Angiogenic sprouting is regulated by endothelial cell expression of Slug [J]. J Cell Sci, 2014, 127(Pt 9): 2017-2028. [9] Huang M, Liu T, Ma P, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma [J]. J Clin Invest, 2016, 126(5): 1801-1814. [10] Gasparics á, Rosivall L, Krizbai IA, et al. When the endothelium scores an own goal: endothelial cells actively augment metastatic extravasation through endothelial-mesenchymal transition [J]. Am J Physiol Heart Circ Physiol, 2016, 310(9): H1055-H1063. [11] Mahmoud MM, Serbanovic-Canic J, Feng S, et al. Shear stress induces endothelial-to-mesenchymal transition via the transcription factor Snail [J]. Sci Rep, 2017, 7(1): 3375. [12] Krizbai IA, Gasparics Á, Nagyöszi P, et al. Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation [J]. PLoS One, 2015, 10(3): e0123845. [13] Ou J, Peng Y, Deng J, et al. Endothelial cell-derived fibronectin extra domain A promotes colorectal cancer metastasis via inducing epithelial-mesenchymal transition [J]. Carcinogenesis, 2014, 35(7): 1661-1670. [14] Ghiabi P, Jiang J, Pasquier J, et al. Breast cancer cells promote a notch-dependent mesenchymal phenotype in endothelial cells participating to a pro-tumoral niche [J]. J Transl Med, 2015, 13:27. [15] Pérez L, Munoz-Durango N, Riedel CA, et al. Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions [J]. Cytokine Growth Factor Rev, 2017, 33:41-54. [16] Liu X, Mujahid H, Rong B, et al. Irisin inhibits high glucose-induced endothelial-to-mesenchymal transition and exerts a dose-dependent bidirectional effect on diabetic cardiomyopathy [J]. J Cell Mol Med, 2018, 22(2): 808-822. [17] Takada S, Hojo M, Tanigaki K, et al. Contribution of endothelial-to-mesenchymal transition to the pathogenesis of human cerebral and orbital cavernous malformations [J]. Neurosurgery, 2017, 81(1): 176-183. [18] Zhou Z, Tang AT, Wong WY, et al. Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling [J]. Nature, 2016, 532(7597): 122-126. [19] Gong F, Zhao F, Gan XD. Celastrol protects TGF-beta1-induced endothelial-mesenchymal transition [J]. J Huazhong Univ Sci Technolog Med Sci, 2017, 37(2): 185-190. [20] Farrar EJ, Butcher JT. Heterogeneous susceptibility of valve endothelial cells to mesenchymal transformation in response to TNFalpha [J]. Ann Biomed Eng, 2014, 42(1): 149-161. [21] Mahler GJ, Farrar EJ, Butcher JT. Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells [J]. Arterioscler Thromb Vasc Biol, 2013, 33(1): 121-130. [22] Landskron G, De la Fuente M, Thuwajit P, et al. Chronic inflammation and cytokines in the tumor microenvironment [J]. J Immunol Res, 2014, 2014:149185. [23] Romero LI, Zhang DN, Herron GS, et al. Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells [J]. J Cell Physiol, 1997, 173(1): 84-92. [24] Rieder F, Kessler SP, West GA, et al. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis [J]. Am J Pathol, 2011, 179(5): 2660-2673. [25] Storr SJ, Safuan S, Ahmad N, et al. Macrophage-derived interleukin-1beta promotes human breast cancer cell migration and lymphatic adhesion in vitro [J]. Cancer Immunol Immunother, 2017, 66(10): 1287-1294. [26] Honda T, Yamamoto I, Inagawa H. Angiogenesis-, metastasis- and signaling pathway-related factor dynamics in human colon cancer cells following interaction with monocytes [J]. Anticancer Res, 2013, 33(7): 2895-2900. [27] Echeverría C, Montorfano I, Sarmiento D, et al. Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells [J]. J Cell Mol Med, 2013, 17(6): 800-814. [28] Liu T, Ma W, Xu H, et al. PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma [J]. Nat Commun, 2018, 9(1): 3439. |